Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-06-10
1986-12-02
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
046265392
ABSTRACT:
Opioid-containing pharmaceutical compositions are provided which are useful in effecting transdermal delivery of a therapeutic dose of the opioid to the systemic circulation of a mammal. These pharmaceutical compositions consist essentially of the opioid, a penetration enhancer which is at least one of a saturated fatty alcohol or fatty acid of 8-15 carbon atoms or of an unsaturated fatty alcohol or fatty acid of 8-18 carbon atoms, and a suitable pharmaceutical carrier, preferably propylene glycol.
REFERENCES:
patent: 3275510 (1966-09-01), Magid et al.
patent: 3592930 (1971-07-01), Katz et al.
patent: 3867528 (1975-02-01), Ritter et al.
patent: 3888995 (1975-06-01), Katz et al.
patent: 3924004 (1975-12-01), Chang et al.
patent: 4091090 (1978-05-01), Sipos
patent: 4299826 (1981-11-01), Luedders
patent: 4405616 (1983-09-01), Rajadhyaksha
patent: 4416886 (1983-11-01), Bernstein
Contact Dermatitis, 1, pp. 65-69, M. A. Stillman et al., (1975).
Aungst Bruce
DiLuccio Robert C.
E. I. DuPont de Nemours and Company
Friedman Stanley J.
LandOfFree
Trandermal delivery of opioids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trandermal delivery of opioids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trandermal delivery of opioids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2292810